Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Presurgical models can effectively and affordably screen cancer prevention agents.

New mouse models help study melanocytic cells for melanoma research.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Lactate production is important for activating hair growth stem cells.

Dermatologists need to understand hair products to treat hair and scalp issues better.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

SOX11 and SOX4 help skin cells act like embryonic cells to heal wounds in mice.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

A new gene, JMJD1C, may affect testosterone levels in men.